Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.
If you have been wondering what to do with Alcon stock lately, you are definitely not alone. With shares closing at $61.12 and recent moves showing a 2.0% gain over the past week and a 3.7% increase ...
The special meeting to vote on the company's $1.5 billion sale to Alcon, originally scheduled for today, has been adjourned ...
ISS is now the third proxy advisory firm to urge Staar Surgical shareholders to reject the upcoming $1.5 billion sale to ...
STAAR Surgical (NASDAQ:STAA) holders should vote against Alcon's (ALC) planned $1.5 billion purchase of the implantable lens ...
Millions of contact lens wearers navigating busy schedules and long hours on screens are seeking a balance of comfort and ...
STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) announced that, in light of ongoing discussions with Alcon (SIX/NYSE: ALC), STAAR’s Special Meeting of ...
STAAR responded by saying, “We urge all STAAR stockholders not to be misled by Broadwood. STAAR is confident that the Alcon transaction maximizes value for STAAR stockholders [and] is the only merger ...
Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its Fort Worth campus. Alcon, which started in Fort Worth and has grown to ...
Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...
Alcon Entertainment “got its ass kicked” financially with the weak box office performance of “Transcendence,” the company’s top executive told TheWrap, saying that the company will lose at least $30 ...
Alcon has bought up Belkin Vision and its laser device for treating glaucoma. The deal includes an upfront transfer of $81 million, including about $65 million in cash—plus the opportunity for up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results